159 related articles for article (PubMed ID: 30907063)
1. HLA-G, HLA-E, and IDO overexpression predicts a worse survival of Tunisian patients with vulvar squamous cell carcinoma.
Boujelbene N; Ben Yahia H; Babay W; Gadria S; Zemni I; Azaiez H; Dhouioui S; Zidi N; Mchiri R; Mrad K; Ouzari HI; Charfi L; Zidi I
HLA; 2019 Jul; 94(1):11-24. PubMed ID: 30907063
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer.
Ben Yahia H; Boujelbene N; Babay W; Ben Safta I; Dhouioui S; Zemni I; Ali Ayadi M; Charfi L; Ouzari HI; Rebmann V; Rizzo R; Mrad K; Driss M; Zidi I
Hum Immunol; 2020 Jun; 81(6):305-313. PubMed ID: 32273131
[TBL] [Abstract][Full Text] [Related]
3. Status of cellular immunity lacks prognostic significance in vulvar squamous carcinoma.
de Jong RA; Toppen NL; Ten Hoor KA; Boezen HM; Kema IP; Hollema H; Nijman HW
Gynecol Oncol; 2012 Apr; 125(1):186-93. PubMed ID: 22155674
[TBL] [Abstract][Full Text] [Related]
4. Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests.
Sznurkowski JJ; Żawrocki A; Emerich J; Sznurkowska K; Biernat W
Gynecol Oncol; 2011 Aug; 122(2):307-12. PubMed ID: 21616522
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy.
Chinn Z; Stoler MH; Mills AM
Histopathology; 2019 Jan; 74(2):256-268. PubMed ID: 30067880
[TBL] [Abstract][Full Text] [Related]
6. Tumoral indoleamine 2,3-dioxygenase expression predicts poor outcome in laryngeal squamous cell carcinoma.
Ye J; Liu H; Hu Y; Li P; Zhang G; Li Y
Virchows Arch; 2013 Jan; 462(1):73-81. PubMed ID: 23179760
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma.
Babay W; Ben Yahia H; Boujelbene N; Zidi N; Laaribi AB; Kacem D; Ben Ghorbel R; Boudabous A; Ouzari HI; Rizzo R; Rebmann V; Mrad K; Zidi I
Hum Immunol; 2018 Jun; 79(6):463-470. PubMed ID: 29499226
[TBL] [Abstract][Full Text] [Related]
8. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
[TBL] [Abstract][Full Text] [Related]
9. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
10. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
[TBL] [Abstract][Full Text] [Related]
11. Association of CXC chemokine receptor type 4 expression and clinicopathologic features in human vulvar cancer.
Shiozaki T; Tabata T; Ma N; Yamawaki T; Motohashi T; Kondo E; Tanida K; Okugawa T; Ikeda T
Int J Gynecol Cancer; 2013 Jul; 23(6):1111-7. PubMed ID: 23765204
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas.
Laimer K; Troester B; Kloss F; Schafer G; Obrist P; Perathoner A; Laimer J; Brandacher G; Rasse M; Margreiter R; Amberger A
Oral Oncol; 2011 May; 47(5):352-7. PubMed ID: 21440489
[TBL] [Abstract][Full Text] [Related]
13. Expression of endogenous hypoxia markers in vulvar squamous cell carcinoma.
Li YZ; Li SL; Li X; Wang LJ; Wang JL; Xu JW; Wu ZH; Gong L; Zhang XD
Asian Pac J Cancer Prev; 2012; 13(8):3675-80. PubMed ID: 23098453
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer.
Sideras K; Biermann K; Yap K; Mancham S; Boor PPC; Hansen BE; Stoop HJA; Peppelenbosch MP; van Eijck CH; Sleijfer S; Kwekkeboom J; Bruno MJ
Int J Cancer; 2017 Aug; 141(3):572-582. PubMed ID: 28470686
[TBL] [Abstract][Full Text] [Related]
15. Age, treatment and prognosis of patients with squamous cell vulvar cancer (VSCC) - analysis of the AGO-CaRE-1 study.
Prieske K; Woelber L; Muallem MZ; Eulenburg C; Jueckstock JK; Hilpert F; de Gregorio N; Iborra S; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Harter P; Wimberger P; Sehouli J; Mahner S
Gynecol Oncol; 2021 May; 161(2):442-448. PubMed ID: 33648748
[TBL] [Abstract][Full Text] [Related]
16. HLA-G Expression is Associated with an Unfavorable Prognosis of Oral Squamous Cell Carcinoma.
Imani R; Seyedmajidi M; Ghasemi N; Moslemi D; Shafaee S; Bijani A
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2527-2533. PubMed ID: 30256047
[TBL] [Abstract][Full Text] [Related]
17. ROCK1 as a novel prognostic marker in vulvar cancer.
Akagi EM; Lavorato-Rocha AM; Maia Bde M; Rodrigues IS; Carvalho KC; Stiepcich MM; Baiocchi G; Sato-Kuwabara Y; Rogatto SR; Soares FA; Rocha RM
BMC Cancer; 2014 Nov; 14():822. PubMed ID: 25380619
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value and clinicopathologic characteristics of L1 cell adhesion molecule (L1CAM) in a large series of vulvar squamous cell carcinomas.
Trietsch MD; Oonk MH; Hawinkels LJ; Bor R; van Eendenburg JD; Ivanova Z; Peters AA; Nijman HW; Gaarenstroom KN; Bosse T
Oncotarget; 2016 May; 7(18):26192-205. PubMed ID: 27028855
[TBL] [Abstract][Full Text] [Related]
19. Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women.
Zannoni GF; Prisco MG; Vellone VG; De Stefano I; Vizzielli G; Tortorella L; Fagotti A; Scambia G; Gallo D
Histopathology; 2011 Nov; 59(5):909-17. PubMed ID: 22092402
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma.
Micheletti L; Preti M; Cintolesi V; Corvetto E; Privitera S; Palmese E; Benedetto C
J Gynecol Oncol; 2018 Sep; 29(5):e61. PubMed ID: 30022627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
